--- title: Buy Evista (Raloxifene) 60mg Pills Online description: Evista (Raloxifene) 60mg pills help prevent osteoporosis in postmenopausal women and reduce breast cancer risk. Choose our secure pharmacy for authentic medication and prompt delivery. type: product language: en url: https://liabilis.com/order-evista-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 24.99 price_max: 431.99 currency: USD offers: - name: 60mg x 10 pills price: 24.99 - name: 60mg x 30 pills price: 64.99 - name: 60mg x 60 pills price: 138.69 - name: 60mg x 90 pills price: 180.99 - name: 60mg x 120 pills price: 229.99 - name: 60mg x 180 pills price: 338.31 - name: 60mg x 360 pills price: 431.99 --- # Buy Evista (Raloxifene) 60mg Pills Online Evista, featuring Raloxifene, is a selective estrogen receptor modulator developed by Eli Lilly. It supports bone health to prevent osteoporosis in postmenopausal women and lowers invasive breast cancer risk. Ideal for women at risk of bone loss. Available in 60mg pills at our trusted online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **60mg** | 10 pills | **$24.99** | $2.47 | In Stock | | **60mg** | 30 pills | **$64.99** | $2.15 | In Stock | | **60mg** | 60 pills | **$138.69** | $2.31 | In Stock | | **60mg** | 90 pills | **$180.99** | $2.01 | In Stock | | **60mg** | 120 pills | **$229.99** | $1.92 | In Stock | | **60mg** | 180 pills | **$338.31** | $1.88 | In Stock | | **60mg** | 360 pills | **$431.99** | $1.20 | In Stock | [Buy Now](https://liabilis.com/order-evista-online-en.html) ## Introduction Evista (generic name Raloxifene) is a selective estrogen receptor modulator (SERM) supplied as a 60 mg oral pill. It belongs to the therapeutic class of bone-protective agents used primarily for postmenopausal osteoporosis and for reducing the risk of invasive breast cancer in certain women. The medication is taken once daily and is available as a single dose strength. ## Quick Reference Facts **Active Ingredient** : Raloxifene **Form** : pill 60 mg **Primary and Off-Label Uses** : • Prevention and treatment of postmenopausal osteoporosis : • Reduction of risk for invasive breast cancer in postmenopausal women with osteoporosis or high-risk profiles : • Investigational use for male osteoporosis (off-label) ## What is Evista? Evista is a brand-named formulation of the active compound raloxifene. It is classified as a selective estrogen receptor modulator, a drug class that exerts estrogen-like effects on bone and cholesterol metabolism while antagonizing estrogen in breast and uterine tissue. The product was developed by Eli Lilly and received regulatory approval in the early 2000s for osteoporosis and later for breast-cancer risk reduction. Because the article is presented under a generic-type framework, Evista is described as the generic version of medications containing the active compound raloxifene. It is marketed under brand names such as **Evista** and **Osseor**, while a chemically identical generic formulation is widely available at lower cost. ## How Evista Works Raloxifene binds to estrogen receptors (ERα and ERβ) with tissue-selective activity. In bone, it mimics estrogen, decreasing osteoclast-mediated bone resorption and modestly increasing bone formation, leading to higher bone mineral density. In breast and uterine tissue, raloxifene acts as an antagonist, preventing estrogen-driven cell proliferation and thereby lowering the incidence of estrogen-sensitive cancers. The drug is absorbed quickly after oral administration (peak plasma concentrations within 2 hours) and undergoes extensive first-pass metabolism via glucuronidation. Its elimination half-life averages 27 hours, supporting once-daily dosing. Raloxifene is excreted primarily in feces, with negligible renal clearance. ## Conditions Treated with Evista - **Postmenopausal Osteoporosis (Prevention & Treatment)** - Raloxifene increases bone mineral density and reduces vertebral fracture risk by inhibiting osteoclast activity. - **Reduction of Invasive Breast Cancer Risk** - In postmenopausal women with osteoporosis or identified high-risk features, raloxifene’s antagonism of estrogen receptors in breast tissue lowers the likelihood of developing invasive disease. - **Secondary Prevention of Osteoporotic Fractures** - For women who have already sustained a vertebral fracture, ongoing treatment helps prevent subsequent fractures. ## Is Evista the Right Medication for You? Evista is most appropriate for postmenopausal women who: - Have a diagnosis of osteoporosis (T-score ≤ -2.5) or osteopenia with additional risk factors. - Require a non-hormonal option for breast-cancer risk reduction, especially if they have a family history or prior atypical hyperplasia. - Prefer a once-daily oral regimen and have no contraindications such as active thromboembolic disease. It may be less suitable for patients with: - Active or history of deep-vein thrombosis, pulmonary embolism, or uncontrolled hypercoagulable states. - Undiagnosed abnormal uterine bleeding or known estrogen-dependent tumors. - Severe hepatic impairment, which can increase drug exposure. - Pregnancy or lactation, because raloxifene can affect fetal development. In such cases, alternative osteoporosis agents (e.g., bisphosphonates, denosumab) or breast-cancer preventive strategies should be considered. ## Buying Evista from [our online pharmacy](https://liabilis.com/order-evista-online-en.html) ### Why Choose Our Service? Accessing Evista can be challenging due to insurance restrictions or limited local stock. Our platform offers a convenient, cost-effective way to obtain the medication, especially for patients seeking a reliable generic alternative. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. All suppliers comply with recognized regulatory frameworks, and each shipment undergoes rigorous verification before dispatch. ### Pricing & Access The generic formulation of raloxifene is offered at a price close to the manufacturer’s acquisition cost, providing significant savings compared with brand-name Evista. Our service also enables delivery to regions where the drug may otherwise be unavailable. ### Discreet Delivery Orders are packaged in plain, unmarked envelopes and shipped via express courier (typically within 7 days) or standard airmail (approximately 3 weeks). Privacy is maintained throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing**: One 60 mg tablet taken orally once daily, preferably with or without food. Do not exceed the recommended dose. - **Missed Dose**: If a dose is forgotten, take it as soon as remembered unless it is near the time of the next scheduled dose. In that case, skip the missed tablet and resume the regular schedule; do not double-dose. - **Suspected Overdose**: Seek immediate medical attention. Symptoms may include nausea, vomiting, dizziness, or signs of thromboembolism. Bring the medication bottle for reference. - **Practical Tips**: Avoid abrupt cessation; gradual discontinuation under physician guidance minimizes rebound bone loss. Limit alcohol consumption, and refrain from operating heavy machinery if you experience severe dizziness or visual disturbances. ## Safety Information ### ⚠️ Who Should Not Take Evista - Known or suspected pregnancy or breastfeeding. - Active deep-vein thrombosis, pulmonary embolism, or other thromboembolic disorders. - Undiagnosed abnormal uterine bleeding. - Severe liver disease (Child-Pugh class C). - Patients with a history of estrogen-dependent malignancies (unless contraindicated by a specialist). ### Common Side Effects - **Hot flashes** (often mild to moderate, may diminish with continued use). - **Leg cramps** and occasional muscle aches. - **Swelling or peripheral edema** in the ankles or feet. - **Nausea** or mild gastrointestinal discomfort. These effects are usually transient; maintaining adequate hydration and avoiding excessive caffeine can help. ### Serious Side Effects (Seek Immediate Medical Help) - **Deep-vein thrombosis or pulmonary embolism** - pain, swelling, shortness of breath, chest pain. - **Stroke or transient ischemic attack** - sudden weakness, speech difficulty, facial droop. - **Severe allergic reaction** - rash, itching, swelling of the face or throat, difficulty breathing. Prompt emergency evaluation is essential for any of these events. ### Drug & Food Interactions - **CYP3A4 inhibitors (e.g., ketoconazole, erythromycin)** - may increase raloxifene plasma levels; monitor for side effects. - **CYP3A4 inducers (e.g., rifampin, carbamazepine)** - may reduce efficacy; dosage adjustment may be required. - **Warfarin** - raloxifene can potentiate anticoagulant effect; INR monitoring is advised. - **Estrogen-containing products (including hormone-replacement therapy)** - antagonistic action may diminish therapeutic benefit and increase thrombotic risk. - **Tamoxifen** - concomitant use may reduce raloxifene’s breast-cancer preventive effect. ## Off-Label and Investigational Uses of Evista - **Male Osteoporosis** - Some clinicians prescribe raloxifene to men with low bone density, supported by modest increases in bone mineral density in clinical studies, though regulatory approval is lacking. - **Prevention of Breast Cancer in High-Risk Men** - Rarely considered; evidence is limited to case reports and small series. - **Adjunct in Psychiatric Disorders** - Preliminary research explores raloxifene’s influence on cognition and mood in schizophrenia, but findings remain investigational. These applications have not received formal approval from health authorities and should only be pursued under specialist supervision. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place away from direct sunlight. - Keep the container tightly closed to protect from moisture. - Discard any tablets that have changed color, smell, or appear broken. - When disposing, follow local pharmacy take-back programs or household waste regulations as appropriate. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Evista?** Yes. Carry the medication in its original packaging with a copy of the prescription label. Check the destination country’s import regulations for personal use quantities. - **Should I take Evista with calcium or vitamin D supplements?** Calcium and vitamin D support bone health and are commonly recommended alongside raloxifene. They do not affect raloxifene’s absorption or efficacy. - **Is it safe to exercise while on Evista?** Weight-bearing and resistance exercises complement the medication’s bone-protective effects. Continue regular activity unless your physician advises otherwise. **Product Information** - **What does an Evista tablet look like?** The generic 60 mg tablet is typically round, bicolored (white and pink), and bears the imprint “RAL 60 MG”. Appearance may vary slightly between manufacturers. - **Can the tablet be split or crushed?** Raloxifene tablets are not scored; splitting may result in unequal dosing. Crushing is not recommended because it can affect absorption and increase gastrointestinal irritation. **Regulatory & Safety Nuances** - **Will Evista appear on a standard drug test?** Raloxifene is not a prohibited substance in most occupational drug-testing panels and is unlikely to be detected in routine screenings. - **Are there special considerations for elderly patients?** Older adults have a higher baseline risk for thromboembolic events; clinicians often monitor for signs of leg swelling or shortness of breath and may adjust dosing accordingly. - **Can I use Evista while participating in competitive sports?** Raloxifene is not listed on World Anti-Doping Agency (WADA) prohibited lists, but athletes should verify with their governing bodies in case of rule changes. **Scientific & Clinical Curiosity** - **What were the pivotal trials leading to approval?** The MORE (Multiple Outcomes of Raloxifene Evaluation) trial demonstrated significant reductions in vertebral fracture risk, while the STAR (Study of Tamoxifen and Raloxifene) trial showed comparable breast-cancer risk reduction to tamoxifen with fewer uterine cancers. - **How does raloxifene differ from other SERMs like tamoxifen?** Raloxifene acts as an estrogen antagonist in breast and uterus while maintaining agonist activity in bone and lipid metabolism. Tamoxifen, by contrast, has partial agonist effects in the uterus, leading to a higher risk of endometrial cancer. ## Glossary **Selective Estrogen Receptor Modulator (SERM)** : A class of compounds that bind to estrogen receptors and produce tissue-specific agonist or antagonist effects. **Bone Mineral Density (BMD)** : A measurement of the amount of mineral (calcium, phosphorus) in a specific volume of bone, used to assess osteoporosis risk. **Half-Life** : The time required for the plasma concentration of a drug to decrease by 50 % after reaching steady state. **Glucuronidation** : A metabolic pathway in the liver where a drug is conjugated with glucuronic acid, enhancing water solubility for excretion. **Thromboembolism** : The formation of a blood clot that travels through the bloodstream and lodges in a vessel, potentially blocking blood flow. ## Disclaimer The information provided about **Evista** is intended for general education and does not replace professional medical consultation. All therapeutic choices, including any off-label applications, should be made under the oversight of a qualified healthcare professional. Readers are presumed to be competent adults capable of making informed health decisions. [our online pharmacy](https://liabilis.com/order-evista-online-en.html) supplies **Evista** to individuals who may encounter limited availability through conventional pharmacies, insurance-based channels, or who are seeking cost-effective generic alternatives. Always discuss with your doctor before initiating, modifying, or discontinuing any medication.